https://www.marketscreener.com/quote/stock/ARROWHEAD-PHARMACEUTICALS-26864651/news/Arrowhead-Pharmaceuticals-Announces-Positive-Interim-Results-from-Phase-1b-Study-of-ARO-HIF2-for-T-35796958/?utm_source=telegram&utm_medium=social&utm_campaign=share